Table 3.
Explanatory variable | Model I | Model II* | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | |
log(1+chest dose)-ipsilateral | 1.96 | 1.45–2.69 | <0.001 | |||
log(1+flank dose)-ipsilateral | 1.09 | 0.88–1.35 | 0.438 | 1.51 | 1.13–2.03 | 0.005 |
Doxorubicin | 2.24 | 0.80–6.22 | 0.123 | 1.49 | 0.36–6.19 | 0.581 |
Age@WT≥10 years | 4.59 | 1.88–11.2 | 0.001 | 14.61 | 4.20–50.1 | <0.001 |
Subgroup of 2,123 participants who did NOT receive chest RT